TerSera Therapeutics

Lexicon bids farewell to top seller Xermelo in reorganization toward R&D pipeline
Endpoints
Thu, 07/30/20 - 11:03 am
Lexicon Pharmaceuticals
Xermelo
R&D
TerSera Therapeutics
AstraZeneca's latest Kondo-izing move: A $250M-plus deal for cancer med Zoladex
Fierce Pharma
Tue, 02/21/17 - 11:14 am
AstraZeneca
Zoladex
TerSera Therapeutics